SU1377112A1 - Preparation for healing wounds - Google Patents
Preparation for healing wounds Download PDFInfo
- Publication number
- SU1377112A1 SU1377112A1 SU813282939K SU3282939K SU1377112A1 SU 1377112 A1 SU1377112 A1 SU 1377112A1 SU 813282939 K SU813282939 K SU 813282939K SU 3282939 K SU3282939 K SU 3282939K SU 1377112 A1 SU1377112 A1 SU 1377112A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- preparation
- ascorbic acid
- healing wounds
- wound healing
- pepsin
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Дл повышени ранозаживл ющей и некролитической активности средство содержит , %: пепсин 15, кислота аскорбинова 30, глюкоза 54,25 и гидроперит 0,75. Средство приготовл ют путем смешени компонентов. I табл.In order to increase wound healing and necrolytic activity, the product contains,%: pepsin 15, ascorbic acid 30, glucose 54.25 and hydroponite 0.75. The preparation is prepared by mixing the components. Table I
Description
соwith
Изобретение относитс к фармакологии, а именно к препаратам, используемым дл ускорени заживлени ран.This invention relates to pharmacology, in particular to preparations used to accelerate wound healing.
Цель изобретени - повышение рано- заживл ющей и некролитической активности препарата.The purpose of the invention is to increase the wound healing and necrolytic activity of the preparation.
Пример. К 15 г сухого медицинского пепсина добавл ют 30 г сухой аскорбиновой кислоты, 34,25 г глюкозы и 0,75 г гидроперита в измельченном виде. Порошкообразную смесь тш,ательно перемешивадат и хран т в плотно закрытой посуде в темном месте. Пример применени препарата в клинике. Больна К., 35 лет, поступила в онкологическую клиническую больницу по поводу хондросаркомы правой подвздошной кости. Операци - резекци таза 24.01.80.Example. To 15 g of dry medical pepsin, 30 g of dry ascorbic acid, 34.25 g of glucose and 0.75 g of hydroperite in ground form are added. The powder mixture is mixed, mixed and stored in a tightly closed container in a dark place. An example of the use of the drug in the clinic. Sick K., 35 years old, was admitted to the Oncologic Clinical Hospital for chondrosarcoma of the right iliac bone. Surgery - pelvic resection 24.01.80.
В послеоперационном периоде развилось нагноение тазовой клетчатки. Из раны высеваетс Ь. СоИ. После применени препарата рана через 6 дней очистилась от некротических тканей, гнойные выделени прекратились и рана зажила.In the postoperative period, the pelvic tissue suppuration developed. From the wound sowed b. SoI. After applying the drug, after 6 days the wound was cleansed of necrotic tissue, the purulent secretions stopped and the wound healed.
Препарат примен лс в следующей прописи, %;The drug is used in the following recipe,%;
Пепсин15Pepsin15
Кислота аскорбинова 30Ascorbic Acid 30
Глюкоза54,25Glucose54.25
Гидроперит0,75Hydroperitol 0.75
Данные, подтверждаюш.ие повышение ра- нозаживл щей и некролитической активности предлагаемого препарата по сравнению с известным, представлены в таблице.The data, confirming the increase in the healing and necrolitic activity of the proposed preparation in comparison with the known, are presented in the table.
5 Сроки очищени ран по способу5 Terms of cleansing wounds by the method
известномуthe famous
предлагаемомуproposed
14,,214, 2
п 10n 10
6,,1 п 286, 1 p 28
Как видно из приведенных данных, препарат ускор ет сроки заживлени ран до 6 дней по сравнению с известным (14 дней).As can be seen from the above data, the drug accelerates the healing of wounds by up to 6 days compared with the known (14 days).
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU813282939A SU1149977A1 (en) | 1981-05-04 | 1981-05-04 | Preparation for healing wounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1377112A1 true SU1377112A1 (en) | 1988-02-28 |
Family
ID=20956005
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU813282939A SU1149977A1 (en) | 1981-05-04 | 1981-05-04 | Preparation for healing wounds |
| SU813282939K SU1377112A1 (en) | 1981-05-04 | 1981-05-04 | Preparation for healing wounds |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU813282939A SU1149977A1 (en) | 1981-05-04 | 1981-05-04 | Preparation for healing wounds |
Country Status (1)
| Country | Link |
|---|---|
| SU (2) | SU1149977A1 (en) |
-
1981
- 1981-05-04 SU SU813282939A patent/SU1149977A1/en active
- 1981-05-04 SU SU813282939K patent/SU1377112A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Опокин А. А. Ферментное лечение ран. - В кн.: Хирурги военно-полевых ранений, Томск, 1931, с. 119-120. * |
Also Published As
| Publication number | Publication date |
|---|---|
| SU1149977A1 (en) | 1985-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0025649A1 (en) | Pharmaceutical composition containing Sanguinaria and Galangal suitable for treatment of periodentitis and tumours | |
| ATE55695T1 (en) | USE OF DEFIBROTIDE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES. | |
| Damholt | Treatment of chronic osteomyelitis: A prospective study of 55 cases treated with radical surgery and primary wound closure | |
| CS277001B6 (en) | Dental mixture and process for preparing thereof | |
| SU1377112A1 (en) | Preparation for healing wounds | |
| Cannon et al. | Rate of epithelial regeneration: a clinical method of measurement, and the effect of various agents recommended in the treatment of burns | |
| RU2322247C1 (en) | Method for treating ulcerous defects at diabetic foot syndrome | |
| Moorhead et al. | Human red cell concentrate for surgical dressings | |
| KR950013759B1 (en) | Phamaceutical agent for promoting wound-healing | |
| RU2067448C1 (en) | Method of preparing hemostatic fibrin paste | |
| JPH05194214A (en) | Wound curing promoter | |
| RU2121358C1 (en) | Medicinal forms for treatment of patients with suppurative wounds and a method of treatment of patients with suppurative wounds | |
| US3017325A (en) | Therapeutic composition for topical application and method of applying the same | |
| EP0393190A1 (en) | Copolymers of vinyl alcohol with vinyl acetate, cross-linked by glutaric dialdehyde, method of obtaining them and a phramaceutical preparation based thereon | |
| US3908018A (en) | Therapeutical and cosmetic composition including N-propionyl-epsilon-amino-caproic acid | |
| RU2095065C1 (en) | Agent for treatment of trophic ulcer and burn in leprosy patients | |
| EP0692254A1 (en) | Medicine for the topical treatment of skin | |
| SU1662564A1 (en) | Antiandrogenic agent "niphtolide" for medical treatment of gyosutism | |
| RU2194509C1 (en) | Powder | |
| RU1810059C (en) | Alveolitis prophylaxis method | |
| RU2076696C1 (en) | Suppository | |
| SU1438792A1 (en) | Medicine for treatment of parodontosis | |
| Connell Jr et al. | Indications for and application of Debricin ficus protease | |
| RU1799595C (en) | Remedy for treating purulent-inflammatory processes | |
| HUNT | Current challenges for wound healing research |